Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Filings indexed 423 across all filing types
Latest filing 2023-02-10 Capital/Financing Update
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
[기재정정]주권관련사채권의취득결정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing titled '주권 관련 사채권의 취득결정' (Decision to Acquire Equity-Related Bonds) and is marked as a '정정신고(보고)' (Correction Report). It details the acquisition of convertible bonds, including terms like interest rates, conversion prices, put/call options, and collateral. This falls under the category of capital and financing updates as it relates to the company's capital structure and debt financing activities.
2023-02-10 Korean
[기재정정]주권관련사채권의취득결정
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a South Korean company (Welbiotech) regarding the 'Acquisition of Equity-Related Bonds' (Convertible Bonds). It details the terms of the bond, including conversion prices, put/call options, and financial summaries of the issuer. This type of disclosure regarding financing activities and capital structure changes falls under the 'Capital/Financing Update' category.
2023-02-10 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Well Biotech regarding the results of a capital issuance (specifically a private placement of convertible bonds). It details the issuance amount, payment date, and security type. This falls under the category of share issuance or capital changes, specifically related to the issuance of convertible debt instruments.
2023-02-09 Korean
주권관련사채권의취득결정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Welbiotech) detailing the acquisition of convertible bonds (CB) issued by another company (DYD). It includes specific terms such as conversion price, maturity, interest rates, and call/put option details. This type of disclosure regarding financing activities, capital structure changes, and investment in debt instruments falls under the 'Capital/Financing Update' category.
2023-02-08 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service and Korea Exchange, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). This is a regulatory filing concerning capital structure changes and financing activities. According to the provided definitions, documents detailing fundraising and financing updates are classified as 'CAP'.
2023-02-07 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and specifically details a correction (정정신고) to the terms of the issuance, such as maturity dates, conversion periods, and payment dates. This falls under the category of capital structure changes and financing updates. According to the provided definitions, documents related to fundraising and financing activities are classified as 'CAP'.
2023-02-03 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.